Abstract P2-16-22: A dose-finding phase lb study of BEZ235 in combination with paclitaxel in patients with HER2-negative, locally advanced or metastatic breast cancer by Gil-Martin, M, Fumoleau, P, Isambert, N, Urruticoechea, A, Beck, JT, Csonka, D, di Tomaso, E, Gaur, A, Roiffe, K, Urban, P, Vincent, G, Campone, M

Get full text